ImmunoSite Technologies

ImmunoSite Technologies was a specialty contract research organization focused on immune monitoring, biomarker assay automation, assay validation, particle testing, and product development support for biopharma, clinical trial, and medical device customers. The company supported immune-based drug discovery and development through GLP-compliant laboratory services and automated assay workflows. Its service offerings included clinical research support, immune monitoring, particle characterization, and assay automation rather than a proprietary therapeutic pipeline. Available sources indicate the company was founded in 2009 in Florida and was later listed as permanently closed. The business appears to have operated as a services provider to biotechnology, pharmaceutical, academic, and clinical trial groups rather than as a drug developer.